Will Mudd was named Chief Financial Officer of Guardian Pharmacy Services, Inc., effective July 1, 2026. As of November 6, 2026, Guardian Pharmacy Services, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 22, 2026, naming 1 appointment (Form 8-K, June 22, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Guardian Pharmacy Services, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Guardian Pharmacy Services, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-22. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Guardian Pharmacy Services, Inc. files it.
Also on the record for Guardian Pharmacy Services, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 5% of the class | 5%+ stakes | Source |
| September 28, 2026 | Stake report, Schedule 13D/A, by Bindley Capital Partners I, LLC | 26.4% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13G, by FMR LLC | 6.5% of the class | 5%+ stakes | Source |
| March 24, 2026 | Stake report, Schedule 13D/A, by Bindley Capital Partners I, LLC | 21.3% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by BROWN ADVISORY INC | 4.54% of the class | 5%+ stakes | Source |
| February 10, 2026 | Stake report, Schedule 13G/A, by Wellington Management Group LLP | 3.1% of the class | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 4.2% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by J. Goldman & Co LP | 2.9% of the class | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G, by Wellington Management Group LLP | 5% of the class | 5%+ stakes | Source |
| October 17, 2025 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.7% of the class | 5%+ stakes | Source |
| August 12, 2025 | Stake report, Schedule 13G/A, by Wellington Management Group LLP | 4.9% of the class | 5%+ stakes | Source |
| August 5, 2025 | Stake report, Schedule 13G/A, by Clearbridge Investments, LLC | 2% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Guardian Pharmacy Services, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Guardian Pharmacy Services, Inc. and the records around it.
Guardian Pharmacy Services, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Clearbridge Investments, LLC also filed stake reports on 4 other companies: Brookfield Renewable Corp (Nov 2026), Clearway Energy, Inc. (Nov 2026), Rice Acquisition Corp 3 (Feb 2026)
- BROWN ADVISORY INC also filed stake reports on 11 other companies: Andersen Group Inc. (Oct 2026), Lumexa Imaging Holdings, Inc. (Aug 2026), Nomad Foods Ltd (Aug 2026)
- J. Goldman & Co LP also filed stake reports on 11 other companies: Andersen Group Inc. (Aug 2026), Grocery Outlet Holding Corp. (Aug 2026), Daedalus Special Acquisition Corp. (May 2026)
Watch Guardian Pharmacy Services, Inc.
Get an email when Guardian Pharmacy Services, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Guardian Pharmacy Services, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Guardian Pharmacy Services, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Guardian Pharmacy Services, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 16 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-22 | In | Chief Financial Officer | 2026-07-01 | 8-K, 2026-06-22 |
Who leads Guardian Pharmacy Services, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Will Mudd, appointed, effective 2026-07-01 (filed 2026-06-22).
New leaders reset buying decisions — get the Full Report on Guardian Pharmacy Services, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Guardian Pharmacy Services, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Guardian Pharmacy Services, Inc.Every change, in the filing's words
Appointed: Will Mudd, Chief Financial Officer, effective 2026-07-01
In connection with Mr. Morris's transition to his new role, Will Mudd, who currently serves as Senior Vice President, Finance of the Company, has been appointed Senior Vice President and Chief Financial Officer of the Company, also effective as of July 1, 2026.
- On June 22, 2026, Guardian Pharmacy Services, Inc. (the "Company") announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026.
- Upon his retirement, Mr. Forbes has agreed to continue as an employee of the Company from July 1 through August 31, 2026 to assist with the transition of his duties.
- The Company also announced on June 22, 2026, that upon Mr. Forbes's retirement, and also effective as of July 1, 2026, David Morris will transition from his current role as Executive Vice President and Chief Financial Officer of the Company to the role of Executive Vice President, Chief Operating Officer.
- Mr. Morris, age 63, has served as Executive Vice President and Chief Financial Officer of the Company since our founding in 2004 and as a member of the Company's board of directors since 2021.
- Prior to co-founding the Company, Mr. Morris served as Chief Financial Officer at Central Pharmacy from 1993 to 2001.
- Mr. Morris previously served as President of the PBM Division at Complete Health from 1991 to 1993 and served as a Certified Public Accountant at Ernst & Young LLP from 1985 to 1991.
- Mr. Morris received a B.S., Accounting from the University of Alabama.
Tools for this story
Each opens in a new tab, filled in for Guardian Pharmacy Services, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.